Bacterial Dissimilation of Citric Acid Carl Robert Brewer Iowa State College
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Aconitic Acid from Sugarcane
Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2007 Aconitic acid from sugarcane: production and industrial application Nicolas Javier Gil Zapata Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Engineering Science and Materials Commons Recommended Citation Gil Zapata, Nicolas Javier, "Aconitic acid from sugarcane: production and industrial application" (2007). LSU Doctoral Dissertations. 3740. https://digitalcommons.lsu.edu/gradschool_dissertations/3740 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. ACONITIC ACID FROM SUGARCANE: PRODUCTION AND INDUSTRIAL APPLICATION A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor in Philosophy In The Interdepartmental Program in Engineering Science by Nicolas Javier Gil Zapata B.S., Universidad Industrial de Santander, Colombia, 1988 December, 2007 ACKNOWLEDGEMENTS I sincerely thank my major advisor Dr. Michael Saska for his guidance, assistance, and continuous support throughout my graduate studies at LSU, and for sharing his knowledge and experience of the sugarcane industry. I extend my sincere appreciation to my committee members: Drs. Ioan Negulescu, Benjamin Legendre, Peter Rein, Donal Day, Armando Corripio, for comments, suggestions and critical review of this manuscript. I thank, Dr. Negulescu for introducing me to exciting field of polymers. -
Aconitic Acid
Target/Host: Aspergillus pseudoterreus for Organic Acids: 3-Hydroxypropionic and Aconitic Acid Jon Magnuson, Nathan Hillson, Phil Laible, John Gladden, Gregg Beckham BETO Peer Review 2019 Technology Session Review Area: Agile BioFoundry March 7, 2019 Goal Statement • Goal: Enable biorefineries to achieve 50% reductions in time to bioprocess scale-up as compared to the current average of around 10 years by establishing a distributed Agile BioFoundry that will productionize synthetic biology. • Outcomes: 10X improvement in Design-Build-Test- Learn cycle efficiency, new host organisms, new IP and manufacturing technologies effectively translated to U.S. industry ensuring market transformation. • Relevance: Public infrastructure investment that increases U.S. industrial competitiveness and enables new opportunities for private sector growth and jobs. 2 | © 2016-2019 Agile BioFoundry Target-Host pair Goal Statement Goal: – Validate the Foundry concept by testing the ABF DBTL infrastructure using complementary T-H pairs – Demonstrate improved efficiency of DBTL cycle and Foundry concept via target-host pair work with Aspergillus pseudoterreus – Target 1: 3-hydroxypropionic acid – Target 2: aconitic acid Outcome: – Increased strain performance to novel targets via DBTL – Use this system to demonstrable improvements to DBTL cycle times – Further development of a robust industrially relevant bacterial host – Developing highly relevant datasets for Learn team Relevance: – Benchmark DBTL cycle performance and improvement across scales with real-world substrates and process configurations – Information from DBTL and Integration efforts will be critical to predictive scale-up and scale-down 3 | © 2016-2019 Agile BioFoundry Quad Chart Overview: T/H A. pseudoterreus Barriers Timeline • Technical: • Start: October 1, 2016 – Ct‐D. Advanced Bioprocess Development • End: September 30, 2019 – Ct‐L. -
(ACO2) Deficiency
RESEARCH ARTICLE Plasma metabolomics reveals a diagnostic metabolic fingerprint for mitochondrial aconitase (ACO2) deficiency Lucia Abela1,2,3, Ronen Spiegel4, Lisa M. Crowther1,2,3, Andrea Klein1¤a, Katharina Steindl3,5, Sorina Mihaela Papuc3,5, Pascal Joset3,5, Yoav Zehavi4, Anita Rauch3,5, Barbara Plecko1,2,3, Thomas Luke Simmons1,2,3¤b* 1 Division of Child Neurology, University Children's Hospital Zurich, Zurich, Switzerland, 2 Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland, 3 Radiz±Rare Disease Initiative a1111111111 Zurich, Clinical Research Priority Program for Rare Diseases, University of Zurich, Zurich, Switzerland, a1111111111 4 Department of Pediatrics B, Emek Medical Center, Afula, Rappaport Faculty of Medicine, Technion, Israel, a1111111111 5 Institute of Medical Genetics, University of Zurich, Schlieren, Switzerland a1111111111 a1111111111 ¤a Current address: Pediatric Neurology, University of Basel Children's Hospital, Basel, Switzerland ¤b Current address: Evolva AG, Reinach, Switzerland * [email protected] OPEN ACCESS Abstract Citation: Abela L, Spiegel R, Crowther LM, Klein A, Mitochondrial respiratory chain dysfunction has been identified in a number of neurodegen- Steindl K, Papuc SM, et al. (2017) Plasma metabolomics reveals a diagnostic metabolic erative disorders. Infantile cerebellar-retinal degeneration associated with mutations in the fingerprint for mitochondrial aconitase (ACO2) mitochondrial aconitase 2 gene (ACO2) has been recently described as a neurodegenera- deficiency. PLoS ONE 12(5): e0176363. https://doi. tive disease of autosomal recessive inheritance. To date there is no biomarker for ACO2 org/10.1371/journal.pone.0176363 deficiency and diagnosis relies on genetic analysis. Here we report global metabolic profiling Editor: Petras Dzeja, Mayo Clinic Rochester, in eight patients with ACO2 deficiency. -
Citrobacter Koseri, Levinea Malonatica
INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Jan. 1990, p. 107-108 Vol. 40, No. 1 0020-7713/90/010107-02$02.oo/o Copyright 0 1990, International Union of Microbiological Societies Correct Names of the Species Citrobacter koseri, Levinea malonatica , and Citrobacter diversus Request for an Opinion WILHELM FREDERIKSEN Department of Diagnostic Bacteriology and Antibiotics, Statens Seruminstitut, DK-2300 Copenhagen S,Denmark The single species carrying the three names Citrobacter koseri, Levinea malonatica, and Citrobacter diversus differs by at least eight characteristics from Citrobacter diversum as described by Werkman and Gillen in 1932. It is obviously not the same organism. Accordingly, the species should not carry the name proposed by Werkman and Gillen. I request that the name Citrobacter diversus be placed on the list of nomina rejicienda. Citrobacter koseri is the correct name. Levinea koseri is a correct combination when the genus Levinea is accepted. The epithet maZoonatica is a later synonym of the epithet koseri. In 1932 Werkman and Gillen (7) proposed a new genus, taxon C. diversum described by Werkman and Gillen in the Citrobacter, containing seven species. The description of following characteristics: motility, production of H,S, and Citrobacter diversum (sic) of Werkman and Gillen was based production of acid from inositol and raffinose. To this can be on two strains. These strains have not been kept available in added production of acid from glycogen, melizitose, starch, collections, and the name C. diversum did not come into and galactose, as Table 1 shows. general use. Ewing and Davis obviously accepted four deviations to In 1970 Frederiksen (4) described a new species which he lead to the statement about reactions “similar to those named Citrobacter koseri. -
Biomedical Applications of Bacteria-Derived Polymers
polymers Review Biomedical Applications of Bacteria-Derived Polymers Jonathan David Hinchliffe, Alakananda Parassini Madappura, Syed Mohammad Daniel Syed Mohamed and Ipsita Roy * Department of Materials Science and Engineering, Faculty of Engineering, University of Sheffield, Sheffield S1 3JD, UK; jhinchliffe3@sheffield.ac.uk (J.D.H.); [email protected] (A.P.M.); smdsyedmohamed1@sheffield.ac.uk (S.M.D.S.M.) * Correspondence: I.Roy@sheffield.ac.uk; Tel.: +44-11-4222-5962 Abstract: Plastics have found widespread use in the fields of cosmetic, engineering, and medical sciences due to their wide-ranging mechanical and physical properties, as well as suitability in biomedical applications. However, in the light of the environmental cost of further upscaling current methods of synthesizing many plastics, work has recently focused on the manufacture of these polymers using biological methods (often bacterial fermentation), which brings with them the advantages of both low temperature synthesis and a reduced reliance on potentially toxic and non-eco-friendly compounds. This can be seen as a boon in the biomaterials industry, where there is a need for highly bespoke, biocompatible, processable polymers with unique biological properties, for the regeneration and replacement of a large number of tissue types, following disease. However, barriers still remain to the mass-production of some of these polymers, necessitating new research. This review attempts a critical analysis of the contemporary literature concerning the use of a number of bacteria-derived polymers in the context of biomedical applications, including the biosynthetic Citation: Hinchliffe, J.D.; Parassini pathways and organisms involved, as well as the challenges surrounding their mass production. -
Interpretive Guide
INTERPRETIVE GUIDE Contents INTRODUCTION .........................................................................1 NUTREVAL BIOMARKERS ...........................................................5 Metabolic Analysis Markers ....................................................5 Malabsorption and Dysbiosis Markers .....................................5 Cellular Energy & Mitochondrial Metabolites ..........................6 Neurotransmitter Metabolites ...............................................8 Vitamin Markers ....................................................................9 Toxin & Detoxification Markers ..............................................9 Amino Acids ..........................................................................10 Essential and Metabolic Fatty Acids .........................................13 Cardiovascular Risk ................................................................15 Oxidative Stress Markers ........................................................16 Elemental Markers ................................................................17 Toxic Elements .......................................................................18 INTERPRETATION-AT-A-GLANCE .................................................19 REFERENCES .............................................................................23 INTRODUCTION A shortage of any nutrient can lead to biochemical NutrEval profile evaluates several important biochemical disturbances that affect healthy cellular and tissue pathways to help determine nutrient -
Carbapenem-Resistant Enterobacteriaceae a Microbiological Overview of (CRE) Carbapenem-Resistant Enterobacteriaceae
PREVENTION IN ACTION MY bugaboo Carbapenem-resistant Enterobacteriaceae A microbiological overview of (CRE) carbapenem-resistant Enterobacteriaceae. by Irena KennelEy, PhD, aPRN-BC, CIC This agar culture plate grew colonies of Enterobacter cloacae that were both characteristically rough and smooth in appearance. PHOTO COURTESY of CDC. GREETINGS, FELLOW INFECTION PREVENTIONISTS! THE SCIENCE OF infectious diseases involves hundreds of bac- (the “bug parade”). Too much information makes it difficult to teria, viruses, fungi, and protozoa. The amount of information tease out what is important and directly applicable to practice. available about microbial organisms poses a special problem This quarter’s My Bugaboo column will feature details on the CRE to infection preventionists. Obviously, the impact of microbial family of bacteria. The intention is to convey succinct information disease cannot be overstated. Traditionally the teaching of to busy infection preventionists for common etiologic agents of microbiology has been based mostly on memorization of facts healthcare-associated infections. 30 | SUMMER 2013 | Prevention MULTIDRUG-resistant GRAM-NEGative ROD ALert: After initial outbreaks in the northeastern U.S., CRE bacteria have THE CDC SAYS WE MUST ACT NOW! emerged in multiple species of Gram-negative rods worldwide. They Carbapenem-resistant Enterobacteriaceae (CRE) infections come have created significant clinical challenges for clinicians because they from bacteria normally found in a healthy person’s digestive tract. are not consistently identified by routine screening methods and are CRE bacteria have been associated with the use of medical devices highly drug-resistant, resulting in delays in effective treatment and a such as: intravenous catheters, ventilators, urinary catheters, and high rate of clinical failures. -
The Clinical Significance of the Organic Acids Test
The Clinical Significance of the Organic Acids Test The Organic Acids Test (OAT) provides an accurate metabolic snapshot of what is going on in the body. Besides offering the most complete and accurate evaluation of intestinal yeast and bacteria, it also provides information on important neurotransmitters, nutritional markers, glutathione status, oxalate metabolism, and much more. The test includes 76 urinary metabolite markers that can be very useful for discovering underlying causes of chronic illness. Patients and physicians report that treating yeast and bacterial abnormalities reduces fatigue, increases alertness and energy, improves sleep, normalizes bowel function, and reduces hyperactivity and abdominal pain. The OAT Assists in Evaluating: ■ Krebs Cycle Abnormalities ■ Neurotransmitter Levels ■ Nutritional Deficiencies ■ Antioxidant Deficiencies ■ Yeast and Clostridia Overgrowth ■ Fatty Acid Metabolism ■ Oxalate Levels ■ And More! The OAT Pairs Well with the Following Tests: ■ GPL-TOX: Toxic Non-Metal Chemical Profile ■ IgG Food Allergy + Candida ■ MycoTOX Profile ■ Phospholipase A2 Activity Test Learn how to better integrate the OAT into your practice, along with our other top tests by attending one of our GPL Academy Practitioner Workshops! Visit www.GPLWorkshops.com for workshop dates and locations. The following pages list the 75 metabolite markers of the Organic Acids Test. Included is the name of the metabolic marker, its clinical significance, and usual initial treatment. INTESTINAL MICROBIAL OVERGROWTH Yeast and Fungal Markers Elevated citramalic acid is produced mainly by Saccharomyces species or Propionibacteria Citramalic Acid overgrowth. High-potency, multi-strain probiotics may help rebalance GI flora. A metabolite produced by Aspergillus and possibly other fungal species in the GI tract. 5-Hydroxy-methyl- Prescription or natural antifungals, along with high-potency, multi-strain probiotics, furoic Acid may reduce overgrowth levels. -
Citrobacter Koseri. II. Serological and Biochemical Examina- Tion of Citrobacter Koseri Strains from Clinical Specimens by B
J. Hyg., Camb. (1975), 75, 129 129 Printed in Great Britain Citrobacter koseri. II. Serological and biochemical examina- tion of Citrobacter koseri strains from clinical specimens BY B. ROWE, R. J. GROSS AND H. A. ALLEN Salmonella and Shigella Reference Laboratory, Central Public Health Laboratory, Colindale Avenue, London NW9 5HT (Received 30 January 1975) SUMMLARY 165 strains of Citrobacter koseri isolated from clinical specimens were studied and their biochemical reactions determined. They were examined serologically by means of a scheme consisting of 14 0 antigens. The sources of the clinical specimens were tabulated and the epidemiological information was summarized. The clinical significance of these findings is discussed. INTRODUCTION Bacterial strains variously described as Citrobacter koseri (Frederiksen, 1970), Citrobacter diversus (Ewing & Davis, 1972) and Levinea malonatica (Young, Kenton, Hobbs & Moody, 1971) should be regarded as members of a single species (Gross & Rowe, 1974). In this publication the name C. koseri has been used for convenience only, pending an agreement on the nomenclature of these organisms. In most genera within the family Enterobacteriaceae, serotyping has been invaluable for the precise identification of strains required in epidemiological investigations. An antigenic scheme for C. koseri has been described (Gross & Rowe, 1974) which initially consisted of seven 0 antigens and was subsequently expanded to 14 0 antigens (Gross & Rowe, 1975). The present study involves the examination of 165 strains from clinical sources. Their biochemical reactions and somatic 0 antigens have been determined and the clinical and epidemiological significance of these findings is discussed. MATERIALS AND METHODS Strains The sources of 165 strains isolated from clinical specimens are shown in Table 1. -
Isolation and Identification of (-)-Methylcitric Acid and 2-Methyl
NOTE Agr. Biol. Chem., 38 (12), 2565•`2566, 1974 isocitric acids as calcium salt.*2 The filtrate was diluted and then adjusted to pH 1.8 with 4N sulfuric acid. Isolation and Identification of (-)- After removal of calcium sulfate and thorough concen Methylcitric Acid and 2-Methyl- tration of the filtrate, the residual sirup was extracted repeatedly with ethyl acetate. The combined extract cis-aconitic Acid from the Culture was evaporated to a sirup, which was then heated until of Candida lipolytica foaming ceased at 100•Ž under reduced pressure in order to dehydrate thoroughly. The residual sirup (ca. 80g) was partitioned between 400ml of ethyl Takeshi TABUCHI, Nobufusa SERIZAWA* acetate and 200ml of water, fifteen transfers counter and Sadahiro OHMOMO current distribution being conducted. After each fraction had been checked by paper chromatographic Faculty of Agriculture, Tokyo University of Education, analysis using ethyl acetate-acetic acid-water (50:12: Komaba, Meguro-ku, Tokyo 10) as a solvent-mixture and bromphenol blue as a Received July 12, 1974 detecting reagent, ethyl acetate phases of fractions No. 1 and No. 2 containing an unknown acid, A Previously, we found that from a mixture of n- (Rf 0.92), were collected and evaporated to dryness. The residue (13g) was suspended in water and neutraliz alkanes a fluoroacetate-tolerant mutant, No. R-2, ed with 0.4N barium hydroxide. By concentrating the derived from Candida lipolytica IFO 1659 produced an solution, a precipitate of barium salt appeared. The appreciable amount of threo-Ds-2-methylisocitric acid which competitively inhibited isocitrate dehydro precipitate collected by filtration was dissolved in 1N hydrochloric acid and extracted with ether. -
Antibiotic-Resistant Bacteria and Gut Microbiome Communities Associated with Wild-Caught Shrimp from the United States Versus Im
www.nature.com/scientificreports OPEN Antibiotic‑resistant bacteria and gut microbiome communities associated with wild‑caught shrimp from the United States versus imported farm‑raised retail shrimp Laxmi Sharma1, Ravinder Nagpal1, Charlene R. Jackson2, Dhruv Patel3 & Prashant Singh1* In the United States, farm‑raised shrimp accounts for ~ 80% of the market share. Farmed shrimp are cultivated as monoculture and are susceptible to infections. The aquaculture industry is dependent on the application of antibiotics for disease prevention, resulting in the selection of antibiotic‑ resistant bacteria. We aimed to characterize the prevalence of antibiotic‑resistant bacteria and gut microbiome communities in commercially available shrimp. Thirty‑one raw and cooked shrimp samples were purchased from supermarkets in Florida and Georgia (U.S.) between March–September 2019. The samples were processed for the isolation of antibiotic‑resistant bacteria, and isolates were characterized using an array of molecular and antibiotic susceptibility tests. Aerobic plate counts of the cooked samples (n = 13) varied from < 25 to 6.2 log CFU/g. Isolates obtained (n = 110) were spread across 18 genera, comprised of coliforms and opportunistic pathogens. Interestingly, isolates from cooked shrimp showed higher resistance towards chloramphenicol (18.6%) and tetracycline (20%), while those from raw shrimp exhibited low levels of resistance towards nalidixic acid (10%) and tetracycline (8.2%). Compared to wild‑caught shrimp, the imported farm‑raised shrimp harbored -
A Review of the Opportunistic Pathogen Citrobacter Freundii in Piglets Post Weaning : Public Health Importance
Sys Rev Pharm 2020;11(9):767-773 A multifaceted review journal in the field of pharmacy A Review of the Opportunistic Pathogen Citrobacter Freundii in Piglets Post Weaning : Public Health Importance Akvyan Rafi Hidayatullah1, Mustofa Helmi Effendi2*, Hani Plumeriastuti3, Freshindy Marissa Wibisono1, Erwan Budi Hartadi1, Eka Dian Sofiana1 1Master Program in Animal Diseases and Veterinary Public Health, Faculty of Veterinary Medicine, Universitas Airlangga. 2Departement of Veterinary Public Health, Faculty of Veterinary Medicine, Universitas Airlangga 3Departement of Veterinary Pathology, Faculty of Veterinary Medicine, Universitas Airlangga UNAIR C-Campus Mulyorejo, Surabaya, Indonesia, 60115. *Corresponding author: Mustofa Helmi Effendi. Department of Veterinary Public Health, Faculty of Veterinary Medicine, Universitas Airlangga, Surabaya, Indonesia, Postal code: 60115. Email: [email protected] ABSTRACT The review study will describe clearly related research about Citrobacter Keywords: Citrobacter freundii, microbiota, piglets, antimicrobial freundii in piglet intestines which has been known to play a very important resistance, public health role in animal health and its effects on aspects of public health. Thus, the existence of Citrobacter freundii as a pathogenic opportunistic bacterium as a Correspondence: result of weaning plays an important role in the formation and maintenance Mustofa Helmi Effendi of the intestinal microbiota which affects the health and growth performance Department of Veterinary Public Health, Faculty of Veterinary